BridgeBio Soars After Drug Gets Nod in Rare Heart Condition

Published on 25 Nov 2024 on Bloomberg · via Yahoo Finance

(Bloomberg) -- BridgeBio Pharma Inc. jumped the most in 16 months after its drug got US regulators’...

Read the rest of the article

Start tracking your investments with Statfolio

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: Alnylam Pharmaceuticals,...

Zacks · via Yahoo Finance 26 Jan 2025

For new and old investors, taking full advantage of the stock market and investing with confidenc...

Zacks · via Yahoo Finance 23 Jan 2025

The United States market has recently experienced a 2.8% increase over the past week and a...

Simply Wall St. · via Yahoo Finance 26 Dec 2024

We recently compiled a list of the 10 Best Performing Biotech Stocks in 2024. In this article, we...

Insider Monkey · via Yahoo Finance 23 Dec 2024

We recently compiled a list of the 10 High Growth Healthcare Stocks to Invest in Now. In this...

Insider Monkey · via Yahoo Finance 2 Dec 2024

Looking at individual holdings, Applovin Corp (APP) accounts for about 3.20% of total assets,...

Zacks · via Yahoo Finance 29 Nov 2024

The SPDR S&P Biotech ETF (XBI) is an exchange-traded fund that tracks the biotechnology segment o...

The Forex Market 27 Nov 2024

BBIO gets a significant boost with the FDA approval of acoramidis for the treatment of adults wit...

Zacks · via Yahoo Finance 26 Nov 2024

Alnylam Pharmaceuticals, Inc. Price and Consensus Alnylam Pharmaceuticals, Inc....

Zacks · via Yahoo Finance 26 Nov 2024

The United States market has shown robust performance, climbing by 2.2% over the past week with a...

Simply Wall St. · via Yahoo Finance 25 Nov 2024